Figure 6. Dihydroethidium (DHE) staining in glomeruli (A), and serum and glucocorticoid-regulated kinase (SGK)1 expression in whole kidney (B) and glomeruli (C) at 8 weeks, and effects of tempol (0–4 weeks) and eplerenone (4–8 weeks) treatments.

Data are expressed as means ± S.E.M.; n = 6 per group. *P<0.05, **P<0.01, compared to high salt (HS)-normal salt (NS) group.